CCL2, C-C motif chemokine ligand 2, 6347

N. diseases: 1157; N. variants: 8
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0521158
Disease: Recurrent tumor
Recurrent tumor
0.040 Biomarker phenotype BEFREE Our study showed that a high frequency of CCL2 positive tumor cells and CD14 positive TAMs are significant risk factors for rapid tumor recurrence. 30368555 2019
CUI: C0521158
Disease: Recurrent tumor
Recurrent tumor
0.040 Biomarker phenotype BEFREE Secretion of C-C motif chemokine ligand 2 (CCL2) in response to local irradiation facilitates the recruitment of migrating CD11b<sup>+</sup> myeloid monocytes and TAM to irradiated sites that initiate vasculogenesis and enable tumor recurrence after radiotherapy. 29791764 2018
CUI: C0521158
Disease: Recurrent tumor
Recurrent tumor
0.040 Biomarker phenotype BEFREE Interruption of either CCL2-CCR2 signaling or cathepsin B function significantly impaired PNI <i>in vivo</i> Correlative studies in human specimens demonstrated that cathepsin B-producing macrophages were enriched in invaded nerves, which was associated with increased local tumor recurrence. 28951461 2017
CUI: C0521158
Disease: Recurrent tumor
Recurrent tumor
0.040 Biomarker phenotype BEFREE These results indicate that suicide gene therapy, together with delivery of MCP-1, eradicates HCC cells and exerts prolonged NK cell-mediated antitumor effects in a model of HCC, suggesting a plausible strategy to prevent tumor recurrence. 17182598 2007